The University of Chicago Header Logo

Connection

Michael Blair to Bevacizumab

Back to Details
This is a "connection" page, showing publications Michael Blair has written about Bevacizumab.
Michael Blair
Connection Strength
4.416
Bevacizumab
  1. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
    View in: PubMed
    Score: 0.546
  2. Foveal Development After Use of Bevacizumab for Aggressive Posterior Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):e185-e187.
    View in: PubMed
    Score: 0.546
  3. Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896.
    View in: PubMed
    Score: 0.524
  4. Re: Good: Bevacizumab for retinopathy of prematurity: treatment when pathology is embedded in a normally developing vascular system (Ophthalmology. 2016;123:1843-1844). Ophthalmology. 2017 10; 124(10):e74-e75.
    View in: PubMed
    Score: 0.486
  5. Reactivation of Retinopathy of Prematurity Three Years After Treatment With Bevacizumab. Ophthalmic Surg Lasers Imaging Retina. 2017 03 01; 48(3):255-259.
    View in: PubMed
    Score: 0.467
  6. Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar; 47(3):280-3.
    View in: PubMed
    Score: 0.436
  7. Clinical Characteristics and Treatment Outcomes in Unilateral Coats Disease: A Global Collaborative Study. Ophthalmol Retina. 2025 Jun; 9(6):570-579.
    View in: PubMed
    Score: 0.200
  8. Macular Sequelae Following Exudative Retinal Detachment After Laser Photocoagulation for Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2020 Dec 01; 51(12):698-705.
    View in: PubMed
    Score: 0.151
  9. Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.
    View in: PubMed
    Score: 0.146
  10. Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
    View in: PubMed
    Score: 0.134
  11. Reply. Retina. 2019 01; 39(1):e2-e4.
    View in: PubMed
    Score: 0.133
  12. Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226). Ophthalmology. 2018 10; 125(10):e70-e71.
    View in: PubMed
    Score: 0.130
  13. PROPHYLACTIC PERIPHERAL LASER AND FLUORESCEIN ANGIOGRAPHY AFTER BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY. Retina. 2018 Apr; 38(4):764-772.
    View in: PubMed
    Score: 0.126
  14. CONCURRENT SCLERAL BUCKLE AND INTRAVITREAL BEVACIZUMAB FOR ADVANCED RETINOPATHY OF PREMATURITY-RELATED RETINAL DETACHMENT. Retin Cases Brief Rep. 2016; 10(2):183-6.
    View in: PubMed
    Score: 0.108
  15. Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol. 2010 Aug; 128(8):1080-1.
    View in: PubMed
    Score: 0.074
  16. Smartphone application links severity of retinopathy of prematurity to early motor behavior in a cohort of high-risk preterm infants. J AAPOS. 2023 02; 27(1):12.e1-12.e7.
    View in: PubMed
    Score: 0.044
  17. Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol. 2021 09; 41(9):2377-2378.
    View in: PubMed
    Score: 0.039
  18. Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization in ocular histoplasmosis. Retin Cases Brief Rep. 2014; 8(1):24-9.
    View in: PubMed
    Score: 0.023
  19. Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab. J AAPOS. 2013 Jun; 17(3):323-5.
    View in: PubMed
    Score: 0.022
  20. Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol. 2012 Aug; 130(8):1000-6.
    View in: PubMed
    Score: 0.021
  21. Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity. Arch Ophthalmol. 2012 Jun; 130(6):801-2.
    View in: PubMed
    Score: 0.021
  22. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011 Sep; 129(9):1234-5.
    View in: PubMed
    Score: 0.020
  23. Intravitreal bevacizumab for neovascular glaucoma. J Ocul Pharmacol Ther. 2009 Oct; 25(5):453-8.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.